Zoetis, formerly Pfizer Animal Health has launched Ovatec Plus, which it claims will make equine faecal collection and in-practice worm count testing quicker and easier.

Ovatec Plus is designed to facilitate the in-house detection of worm burdens…

Zoetis, formerly Pfizer Animal Health, has launched Flexi4, a nutritional supplement for horses containing a patented combination of natural plant extracts designed to help maintain joint flexibility and the management of joint pain.

Flexi4 contains…

Zoetis has launched UlcerGold (omeprazole) for the treatment - and prevention of recurrence - of gastric ulcers in horses and foals, presented in a syringe suitable for foals from four weeks of age and horses from 70 to 700kg.

Equine Gastric Ulceration…

Zoetis has announced the launch of Contacera (meloxicam) 15mg/ml oral suspension, a non-steriodal anti-inflammatory preparation for horses.

According to the company, meloxicam has been shown to hold advantages over Phenylbutazone for the alleviation of…

Zoetis has announced the introduction of Equimidine solution in a 50% larger plastic bottle.

The company says the new 15ml multi-dose presentation, now in plastic rather than glass, offers greater safety, as well as cost-saving advantages to practices…

Zoetis, the maker of UlcerGold, has announced the launch of a digital tool to support veterinary surgeons with the diagnosis of Equine Gastric Ulceration Syndrome (EGUS).

The new tool is part of a package that also includes posters and SMS texts to…

Zoetis has announced that its Equip EHV 1,4 vaccine is now available and that it has made arrangements to supply an alternative rotavirus vaccine when Equip Rotavirus goes out of stock later this month.

Equip EHV 1,4 is licensed for the active immunisation…

Zoetis has announced that its equine viral arteritis (EVA) vaccine, Equip Artervac, is back in stock.

The company warned last year that Equip Artervac would be out of stock from the end of November 2017 until mid-2018, but says that the re-availability…

Zoetis has announced that it will continue to supply an alternative equine rotavirus vaccine under a Wholesale Dealer Import Certificate (WDIC) until normal supply of its licensed product, Equip Rotavirus, can be restored.

Zoetis reports that its stock of Equip Artervac, its Equine Viral Arteritis (EVA) vaccine, is due to expire on 13th December, and new stocks are not expected before February 2019.

Equip Artervac is indicated for the active immunisation for horses against…

Zoetis has announced that announced its Equine Viral Arteritis (EVA) vaccine Equip Artervac is now back in stock.

Supplies of the vaccine, which is indicated for the active immunisation for horses against equine arteritis, ran low at the end of last year…

Aware that many horse owners will be worried about the outbreak of equine flu and want to know more about available vaccines, Zoetis has issued a statement for veterinary professionals about its vaccines, Equip Flu and Equip Flu and Tetanus (Equip F or Equip…

Zoetis has launched Stablelab, a hand-held, point-of-care blood test that gives veterinary surgeons diagnostic information about equine inflammation in 10 minutes.

The Stablelab hand-held reader detects and quantifies the biomarker Serum Amyloid A (SAA…

Zoetis has announced a supply problem with Equip Artervac, its vaccine against equine viral arteritis

The current inventory of Equip Artervac has an expiry date of March 29, 2023 and the company is not expecting a new batch to be available until the end…

Zoetis has been granted a Wholesale Dealer Import Certificate (WDIC) to supply practices with an alternative rotavirus vaccine after being hit by manufacturing delays with this year’s season of Equip Rotavirus.

Practices which want to buy the alternative…

Zoetis has added AI equine faecal egg count analysis to its diagnostics platform, Vetscan Imagyst.

Dr Wendy Talbot BVSc DipECEIM MRCVS, Equine National Veterinary Manager at Zoetis said: “Fast equine faecal egg count results are crucial for the appropriate…

Zoetis has announced a further delay in the supply of Equip Artervac in the UK, due to a manufacturing issue.

The company now expects the vaccine will not be available until June 2025.

The company apologised for the  disruption and inconvenience and says…